Invasive Prostate Carcinoma — Trials

Invasive Prostate Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

440 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 139
Recruiting: 65
Ph III recruiting: 5
Growth YoY: —
Industry share: 4%
Top sponsor: Jonsson Comprehensive Cancer Center
Termination share: 31.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (72)

clinicaltrialsPublishedShowing 51–100 of 152 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03246347	A Trial of Androgen Deprivation, Docetaxel, and Enzalutamide for Metastatic Prostate Cancer	active not recruiting	Phase 2	40	Wake Forest University Health SciencesOTHER	1	Jul 29, 2026	clinicaltrials
NCT03456843	Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate Cancer	active not recruiting	Phase 2	190	Yale UniversityOTHER	6	Jul 24, 2026	clinicaltrials